Biocon LimitedNSE: BIOCON

Press Release May 21 2024

· Issued by Biocon Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-21-2024-10

Biocon Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili . Enters U.S. Ophthalmology Market".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases